Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|December 15, 2012
[Synthesis of a supermolecular nanoparticle γ-hy-PC/Ada-Dox and its antitumor activity]Yong-bin Li, Kai Wang, Tian-nan Hu, et al.Journal of Cancer Research and Clinical Oncology|April 29, 2014
Sorafenib enhances effects of transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysisQi-Han Fu, Qi Zhang, Xue-Li Bai, et al.Zhejiang Da Xue Xue Bao. Yi Xue Ban = Journal of Zhejiang University. Medical Sciences|December 15, 2012
[Characteristics of cationic polymers PEI-CyD, PEI-PHPA, PEE-PHPA and PEI25kD in vitro and in vivo]Qi Yao, Xue Jin, Tian-nan Hu, et al.Japanese Journal of Clinical Oncology|October 2, 2018
Combination of transarterial chemoembolization and sorafenib improves outcomes of unresectable hepatocellular carcinoma: an updated systematic review and meta-analysisPiao-Piao Jin, Shi-Yi Shao, Wang-Teng Wu, et al.Oncotargets and Therapy|February 27, 2020
Primary Hepatic Neuroendocrine Tumor Mimicking Ruptured Hepatocellular Carcinoma with AFP Elevation: A Case Report and Literature ReviewHai-Feng Huang, Piao-Piao Jin, Han-Jin Yang, et al.Cancer Research|February 4, 2016
Hypoxia-Induced Epithelial-to-Mesenchymal Transition in Hepatocellular Carcinoma Induces an Immunosuppressive Tumor Microenvironment to Promote MetastasisLong-Yun Ye, Wei Chen, Xue-Li Bai, et al.Molecular Cancer Therapeutics|May 29, 2014
Inhibition of protein phosphatase 2A enhances cytotoxicity and accessibility of chemotherapeutic drugs to hepatocellular carcinomasXue-Li Bai, Qi Zhang, Long-Yun Ye, et al.Cancer Letters|July 12, 2012
NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cellsQi-Da Hu, Wei Chen, Tian-Lian Yan, et al.Pageof 2